Published 9 October 2009, doi:10.1136/bmj.b4155
Cite this as: BMJ 2009;339:b4155

News

US loses clinical research crown as trials move to eastern Europe and developing countries

Bob Roehr

1 Washington, DC

The first 150 words of the full text of this article appear below.

The United States "has slowly lost pace with the rest of the world," when it comes to clinical research, a meeting heard on 7 October.

Jeffrey Drazen, editor in chief of the New England Journal of Medicine, who made the comments, added, "We were at one time seven leagues ahead of everyone else, and now I think we are in a horse race where we can see the competition." He was speaking at the opening of an Institute of Medicine workshop designed to examine the state of clinical research in the US, to identify strengths and weaknesses, and to consider transformative strategies for improving the ways clinical research is organised and conducted, held in Washington, DC.

Professor Drazen, who works at Harvard School of Public Health, called clinical research "the key interface between scientific discovery and medical utility." The nature of the disease and intervention, such as a short . . . [Full text of this article]


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to StumbleUpon StumbleUpon   Add to Technorati Technorati    What's this?

Access jobs at BMJ Careers
Whats new online at Student BMJ